Humans are continually exposed to a wide variety of chemicals, some of which may act as initiators, promoters, cocarcinogens, and/or complete carciongens. Current evidence suggest that tumor promotion plays an important role in the etiology of human cancer. Although the phorbol ester promoters have been widely studied, much less is known about the mechanism of action of anthrone tumor promoters. While there are some similarities between phorbol esters and the anthrones we have obtained evidence that there are also some significant differences in their effects on mouse skin. In addition, indirect evidence which we hav obtained suggests that oxidation of anthrones and generation of free radicals is involved in their skin tumor promoting action. The current proposal will continue to explore the mechanism of skin tumor promotion by anthrones. Specifically, we will explore the role of anthrone oxidation and generation of free radicals in skin tumor promotion by this class of compounds. The specific amis of the proposal are as follows: (1) To further characterize skin tumor promotion and progression by anthrone derivatives as follows: a) to examine the regression kinetics of papillomas generated with various treatment protocols; b) to determine the ability of anthrone derivatives to enhance progression of pre- existing papillomas to carcinomas; and c) to further characterize the phenomenon of delayed promotion leading to enchanced promoting activity of anthrones; (2) To determine the ability of anthrones to induce or activate polyamine interconversion pathways in relation to epidermal toxicity and their skin tumor promoting activity; (3) To determine the relationship(s) between epidermal toxicity and anthrone mediated skin tumor promotion; (4) To examine the nonenzymatic and enzymatic mechanisms for oxidation of anthrones in mouse epidermis in relation to skin tumor promotion. Initial experiments indicate an excellent correlation between the ability to undergo base catalyzed oxidation and skin tumor promoting activity; (5) To determine the nature of the reactive products of anthrone oxidation; (6) To determine the ability of anthrones to modulate oxidant defense systems in mouse epidermis; and (7) To determine the ability of antioxidants to modulate skin tumor promotion by anthrones. This experimental approach will allow us to test the hypothesis that anthrone skin tumor promoters work by a mechanism which involves oxidation and subsequent generation of free radical intermediates.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA037111-06
Application #
3174803
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1983-08-01
Project End
1993-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Organized Research Units
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Rho, Okkyung; Kiguchi, Kaoru; Jiang, Guiyu et al. (2014) Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild-type and BK5.AktWT mice. Mol Carcinog 53:871-82
Checkley, L Allyson; Rho, Okkyung; Angel, Joe M et al. (2014) Metformin inhibits skin tumor promotion in overweight and obese mice. Cancer Prev Res (Phila) 7:54-64
Hursting, Stephen D; Digiovanni, John; Dannenberg, Andrew J et al. (2012) Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila) 5:1260-72
Carr, Theresa D; DiGiovanni, John; Lynch, Christopher J et al. (2012) Inhibition of mTOR suppresses UVB-induced keratinocyte proliferation and survival. Cancer Prev Res (Phila) 5:1394-404
Rho, Okkyung; Kim, Dae Joon; Kiguchi, Karou et al. (2011) Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog 50:264-79
Checkley, L Allyson; Rho, Okkyung; Moore, Tricia et al. (2011) Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Prev Res (Phila) 4:1011-20
Kiguchi, Kaoru; Kitamura, Takuya; Moore, Tricia et al. (2010) Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis. Cancer Prev Res (Phila) 3:940-52
Hursting, Stephen D; Perkins, Susan N; Lavigne, Jackie A et al. (2009) Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice. Mol Carcinog 48:671-7
Moral, Marta; Segrelles, Carmen; Martínez-Cruz, Ana Belén et al. (2009) Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma. In Vivo 23:653-60
Abel, Erika L; Angel, Joe M; Kiguchi, Kaoru et al. (2009) Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc 4:1350-62

Showing the most recent 10 out of 58 publications